Boston Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-30,608
| Closed | -$3.76M | – | 652 |
|
|
2018
Q3 | $3.76M | Sell |
30,608
-100,873
| -77% | -$12.4M | 0.16% | 207 |
|
|
2018
Q2 | $12.9M | Buy |
131,481
+111,896
| +571% | +$11M | 0.32% | 76 |
|
|
2018
Q1 | $1.62M | Buy |
19,585
+7,100
| +57% | +$589K | 0.04% | 295 |
|
|
2017
Q4 | $969K | Buy |
+12,485
| New | +$969K | 0.02% | 372 |
|